A Randomized Trial Investigating the Efficacy and Safety of Water Soluble Micellar Paclitaxel (Paccal Vet) for Treatment of Nonresectable Grade 2 or 3 Mast Cell Tumors in Dogs

Prospective Randomized Clinical Trial Assessing the Efficacy of Denamarin for Prevention of CCNU-Induced Hepatopathy in Tumor-Bearing Dogs

(2011) K.A. Skorupski et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Efficacy of Maropitant in the Prevention of Delayed Vomiting Associated with Administration of Doxorubicin to Dogs

(2010) S.E. Rau et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

(2009) C. A. London et al.   CLINICAL CANCER RESEARCH

Efficacy of Vinblastine for Treatment of Canine Mast Cell Tumors

(2009) K.M. Rassnick et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors

(2009) K.A. Hahn et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors

(2008) S. Letard et al.   MOLECULAR CANCER RESEARCH

Dose-escalating vinblastine for the treatment of canine mast cell tumour

(2008) K. R. Vickery et al.   Veterinary and Comparative Oncology